19 July 2020>: Database Analysis
Systematic Profiling of Alternative Splicing for Sarcoma Patients Reveals Novel Prognostic Biomarkers Associated with Tumor Microenvironment and Immune Cells
Chuan Hu 1ABCEF , Yuanhe Wang 1ABC , Chuan Liu 2DEF , Rui Shen 1DE , Bo Chen 3F , Kang Sun 1B , Huili Rao 4C , Lin Ye 3E , Jianjun Ye 3C , Shaoqi Tian 1ABCDEF*DOI: 10.12659/MSM.924126
Med Sci Monit 2020; 26:e924126
Figure 2 Prognostic AS events in the SARC cohort. (A) The top 20 significant OS-AS events for 7 splicing types (except ME). (B) The top 20 significant DFS-AS events for 7 splicing types (except ME). SARC – sarcoma; OS – overall survival; ME – mutually exclusive exon; DFS – disease-free survival.